Malaria Positive Cases with Reference to Liver Function Test among Patients Attending in Teerthanker Mahaveer Medical College and Research Centre, Moradabad, Uttar Pradesh, India

Introduction: Malaria is also an important infectious vector-borne disease caused by a Plasmodium species. According to the World Health Organization, involvement of liver in Plasmodium Falciparum malaria is not an uncommon presentation and presence of jaundice (bilirubin ≥3 mg/dl) is one of the signs of malaria. In severe and complicated malaria, a term “malarial hepatitis” is commonly used to describe hepatocytic dysfunction; however, actual inflammation is almost never seen in the liver parenchyma. An increased level of serum bilirubin along with increased level of serum glutamate pyruvate transaminase (SGPT) to more than three times the upper limit of normal, is main characteristics of malarial hepatitis. Materials and Methods: This study was performed on 80 peripheral blood smear (PBS) confirmed cases of malaria. A collection of blood sample was done by venepuncture under aseptic conditions in the ethylenediaminetetraacetic acid tube for the diagnosis of malaria and in a plane vial to perform liver function test (LFT). Diagnosis of malaria was done by the microscopy of PBS and rapid malarial antigen test. The LFT was performed using autoanalyzer and Erba biodiagnostic kit, according to manufacturer instructions. Results: Out of total 80 malaria positive patients, 60 patients (75%) had got deranged LFT in which 35 (70%) were males and 25 (83.33%) were females. According to serum bilirubin levels, patients were classified into three Groups A (59 patients, serum bilirubin <3 mg/dl), B (21 patients, serum bilirubin 3-10 mg/dl), and C (no patient, serum bilirubin >10 mg/dl). Total malaria positive patients had total bilirubin, direct bilirubin, indirect bilirubin, serum glutamic oxaloacetic transaminase, SGPT, and alkaline phosphatase levels in the range of 2.17 ± 1.78 mg/dl, 0.88 ± 0.77 mg/dl, 1.29 ± 1.12 mg/dl, 45.88 ± 28.99 IU/L, 41.04 ± 26.45 IU/L, and 104.48 ± 67.51 U/L, respectively. Conclusion: Liver dysfunction in malarial infection ranged from mild elevation of liver enzymes and serum bilirubin (≥3 mg/dl) to acute hepatitis. It indicates severe illness with a high frequency of complications and mortality rates.

[1]  P. Jadhav,et al.  Hematological aspects in malaria , 2013 .

[2]  H. Chandra,et al.  Role of Haematological Parameters as an Indicator of Acute Malarial Infection in Uttarakhand State of India , 2013, Mediterranean journal of hematology and infectious diseases.

[3]  M. Molyneux,et al.  Liver pathology in Malawian children with fatal encephalopathy. , 2011, Human pathology.

[4]  L. Otieno,et al.  Impact of Plasmodium falciparum infection on haematological parameters in children living in Western Kenya , 2010, Malaria Journal.

[5]  A. Abro,et al.  Jaundice with hepatic dysfunction in P. falciparum malaria. , 2009, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[6]  Y. Joshi,et al.  Acute hepatic failure due to Plasmodium falciparum liver injury. , 2008, Liver.

[7]  I. Mueller,et al.  Plasmodium malariae and Plasmodium ovale--the "bashful" malaria parasites. , 2007, Trends in parasitology.

[8]  A. Anand,et al.  Jaundice in malaria , 2005, Journal of gastroenterology and hepatology.

[9]  Tomoko Ishino,et al.  Liver invasion by malarial parasites – how do malarial parasites break through the host barrier? , 2004, Cellular microbiology.

[10]  S. Mohanty,et al.  The influence of hyperbilirubinaemia on malaria-related mortality: an analysis of 1103 patients , 2004, Annals of tropical medicine and parasitology.

[11]  R. Pokharna,et al.  Hepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malaria. , 2003, QJM : monthly journal of the Association of Physicians.

[12]  R. Handa,et al.  Plasmodium vivax and hepatitis E co-infection--a rare cause of malarial jaundice. , 2002, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[13]  A. Misore,et al.  Red cell surface changes and erythrophagocytosis in children with severe plasmodium falciparum anemia. , 2000, Blood.

[14]  S. Looareesuwan,et al.  Liver profile changes and complications in jaundiced patients with falciparum malaria. , 1994, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[15]  A. Narula,et al.  Malarial hepatitis: a heterogeneous syndrome? , 1992, The National medical journal of India.

[16]  M. Molyneux,et al.  Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. , 1989, The American journal of tropical medicine and hygiene.

[17]  R. Ahuja,et al.  Falciparum malaria--present day problems. An experience with 425 cases. , 1989, The Journal of the Association of Physicians of India.

[18]  O. Doumbo,et al.  Malaria and the Red Cell , 1982, The Lancet.

[19]  L. Perrin,et al.  The hematology of malaria in man. , 1982, Seminars in hematology.

[20]  Patel,et al.  PLASMODIUM FALCIPARUM VERSUS PLASMODIUM VIVAX: WHICH IS A LESSER EVIL? , 2012 .

[21]  P. Arguin,et al.  271 – Plasmodium Species (Malaria) , 2012 .

[22]  Weltgesundheitsorganisation World malaria report , 2005 .

[23]  K. Mendis,et al.  The neglected burden of Plasmodium vivax malaria. , 2001, The American journal of tropical medicine and hygiene.

[24]  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  W. Wernsdorfer,et al.  The clinical features of malaria. , 1988 .

[26]  H. Tandon,et al.  Malarial hepatitis. , 1955, Journal of the Indian Medical Association.